当前位置:首页 - 行情中心 - 国药一致(000028) - 财务分析

国药一致

(000028)

  

流通市值:117.31亿  总市值:136.58亿
流通股本:4.78亿   总股本:5.57亿

国药一致(000028)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润3.05亿元,每股收益0.52元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益2191270.36万元,未分配利润1379523.68万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产4912377.62万元,负债2721107.26万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入17,823,409,770.3173,415,858,423.1355,124,490,690.3436,796,598,397.42
营业总成本17,432,136,489.271,812,830,420.1953,874,589,496.9835,955,918,659.01
其他经营收益
营业利润376,586,868.981,512,828,830.821,333,477,586.93926,496,477.17
利润总额376,860,528.731,509,020,328.671,317,654,842.06918,113,302.33
净利润305,160,963.771,128,348,677.761,019,397,384.05712,593,802.45
每股收益
其他综合收益-1,970,509.18-36,254.21-36,254.21
综合收益总额305,160,963.771,130,319,186.941,019,361,129.84712,557,548.24
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计40,308,348,201.2840,195,752,541.7141,167,628,746.6140,862,745,995.81
非流动资产:
非流动资产合计8,815,427,984.818,900,518,437.329,391,233,834.079,563,389,791.15
资产总计49,123,776,186.0949,096,270,979.0350,558,862,580.6850,426,135,786.96
流动负债:
流动负债合计25,897,591,583.5126,105,142,816.6127,461,409,962.0527,463,387,041.37
非流动负债:
非流动负债合计1,313,481,025.091,366,643,608.911,551,778,976.771,712,326,820.55
负债合计27,211,072,608.627,471,786,425.5229,013,188,938.8229,175,713,861.92
所有者权益(或股东权益):
归属于母公司股东权益合计18,897,425,775.8918,609,963,275.5718,429,946,171.4918,136,171,801.7
股东权益合计21,912,703,577.4921,624,484,553.5121,545,673,641.8621,250,421,925.04
负债和股东权益合计49,123,776,186.0949,096,270,979.0350,558,862,580.6850,426,135,786.96
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计17,348,365,372.178,834,075,364.3455,641,036,328.436,741,745,189.28
经营活动现金流出小计20,283,698,848.577,195,486,439.0756,104,112,748.8136,726,678,499
经营活动产生的现金流量净额-2,935,333,476.41,638,588,925.27-463,076,420.4115,066,690.28
投资活动产生的现金流量:
投资活动现金流入小计3,754,957.93122,475,880.94104,098,576.3950,731,325.01
投资活动现金流出小计26,970,163.32225,400,701.72181,176,558.24114,799,722.07
投资活动产生的现金流量净额-23,215,205.39-102,924,820.78-77,077,981.85-64,068,397.06
筹资活动产生的现金流量:
筹资活动现金流入小计767,158,810.651,761,780,819.61,566,290,860.141,077,469,213.33
筹资活动现金流出小计434,764,302.193,124,007,020.962,880,143,761.581,740,308,910.55
筹资活动产生的现金流量净额332,394,508.46-1,362,226,201.36-1,313,852,901.44-662,839,697.22
汇率变动对现金及现金等价物的影响-566.2-74,016.45-73,715.79-74,564.57
现金及现金等价物净增加额-2,626,154,739.53173,363,886.68-1,854,081,019.49-711,915,968.57
期末现金及现金等价物余额4,670,853,678.027,297,008,417.555,269,563,511.386,411,728,562.3
补充资料:
现金及现金等价物的净增加额-173,363,886.68--711,915,968.57
最新报告期:2026-04-23
研究机构分析师预测每股收益(元)更新日
2026年2027年2028年
中金公司夏璐,张琎,朱言音2.182.41--2026-04-23
信达证券唐爱金,章钟涛2.282.442.592026-04-15
中信证券宋硕,陈竹,张斌斌2.192.402.652026-04-13
中信建投袁全,刘若飞,沈兴熙,贺菊颖2.212.372.562026-04-12
西南证券杜向阳2.292.352.822026-04-07
TOP↑